Glioma spheroids obtained via ultrasonic aspiration are viable and express stem cell markers: a new tissue resource for glioma research. (Q47932798)

6 February 2018

title

Glioma spheroids obtained via ultrasonic aspiration are viable and express stem cell markers: a new tissue resource for glioma research. (English)

1 reference

6 February 2018

author

Henrik D Schrøder

4

1 reference

6 February 2018

author name string

Stine Skov Jensen

1

1 reference

6 February 2018

Charlotte Aaberg-Jessen

2

1 reference

6 February 2018

Claus Andersen

3

1 reference

6 February 2018

Bjarne Winther Kristensen

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 November 2013

1 reference

6 February 2018

published in

Neurosurgery

1 reference

6 February 2018

volume

73

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

page(s)

868-86; discussion 886

1 reference

6 February 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

cites work

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Comparative analysis of DNA repair in stem and nonstem glioma cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Brain tumor stem cells: bringing order to the chaos of brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Tumor cells from ultrasonic aspirations of glioblastomas migrate and form spheres with radial outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Successful laboratory growth and analysis of CUSA-obtained medulloblastoma samples. Technical note.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Evaluation of the histopathology of brain tumor tissue obtained by ultrasonic aspiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Immunocytochemical evaluation of central nervous system tumors obtained by the Cavitron ultrasonic surgical aspirator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Evaluation of histological appearance of tissues removed by cavitron ultrasonic surgical aspirator (CUSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Multicellular tumor spheroids from human gliomas maintained in organ culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Multipotent, dedifferentiated cancer stem-like cells from brain gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

21 January 2018

Brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Cancerous stem cells can arise from pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

CD133 identifies perivascular niches in grade II-IV astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Bmi1, stem cells, and senescence regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Cellular signaling in normal and cancerous stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Expression of stem cell markers in human astrocytomas of different WHO grades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

CNS stem cells express a new class of intermediate filament protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Phosphorylation state of Olig2 regulates proliferation of neural progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Determination of EGFR status in gliomas: usefulness of immunohistochemistry and fluorescent in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Pediatric glioblastomas: a histopathological and molecular genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells: the utility of fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Hypoxia inducible factors in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Long-term culture of organotypic multicellular glioma spheroids: a good culture model for studying gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Cytolytic effects of autologous lymphokine-activated killer cells on organotypic multicellular spheroids of gliomas in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Quantification of viability in organotypic multicellular spheroids of human malignant glioma using lactate dehydrogenase activity: a rapid and reliable automated assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Growth of precultured human glioma specimens in nude rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Angiogenesis-independent tumor growth mediated by stem-like cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

CD133 is a marker of bioenergetic stress in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0000000000000118

10.1227/NEU.0000000000000118

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

23887192

1 reference

6 February 2018